Literature DB >> 21621419

P2X7 receptor positively regulates MyD88-dependent NF-κB activation.

Yanhui Liu1, Yajuan Xiao, Zhiyuan Li.   

Abstract

Recent studies have demonstrated that P2X7 plays a critical role in the immune system. Here, our results showed that P2X7 activated a NF-κB - but not an IFN-β-dependent luciferase reporter gene in HEK293T cells. P2X7 was involved in the LPS- and ATP-induced NF-κB activation but did not significantly impact the response to Zymosan in RAW264.7 cells. The activation of NF-κB and IFN-β induced by myeloid differentiation primary-response protein 88 (MyD88) was enhanced by P2X7 co-expression. The siRNA silencing MyD88 almost abolished the NF-κB activation induced by P2X7, and co-immunoprecipitation showed that P2X7 interacted with MyD88. The amino acids in the C-terminus, especially the LPS-binding region of P2X7, were critical for the cellular localization and immune function of P2X7. P2X7ΔC (190 amino acids deleted in the C-terminus) and P2X7 G586A variants localized throughout the cytoplasma with a little aggregation, which differs from the cell membrane localization of wild type P2X7. Both of them could not localize to Golgi or endoplasmic reticulum. P2X7ΔC and P2X7 G586A had impaired proteolytic cleavage of caspase-1 into the functional p20 subunit, which can activate pro-inflammatory cytokines such as IL-1β. P2X7 G586A also showed a slight interaction with MyD88 in our co-immunoprecipitation experiment. This interaction might result in the attenuated activation of NF-κB and IFN-β induced by MyD88.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621419     DOI: 10.1016/j.cyto.2011.05.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

1.  Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.

Authors:  Hayley Goullee; Antonia L Wadley; Catherine L Cherry; Richard J N Allcock; Michael Black; Peter R Kamerman; Patricia Price
Journal:  J Neurovirol       Date:  2016-01-19       Impact factor: 2.643

2.  P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity.

Authors:  Luiz Eduardo Baggio Savio; Paola de Andrade Mello; Stephanie Alexia Cristina Silva Santos; Júlia Costa de Sousa; Suellen D S Oliveira; Richard D Minshall; Eleonora Kurtenbach; Yan Wu; Maria Serena Longhi; Simon C Robson; Robson Coutinho-Silva
Journal:  J Cell Sci       Date:  2020-03-06       Impact factor: 5.285

3.  The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control.

Authors:  Vanessa Ribeiro Figliuolo; Suzana Passos Chaves; Luiz Eduardo Baggio Savio; Maria Luiza Prates Thorstenberg; Érika Machado Salles; Christina Maeda Takiya; Maria Regina D'Império-Lima; Herbert Leonel de Matos Guedes; Bartira Rossi-Bergmann; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2016-11-19       Impact factor: 3.765

4.  Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.

Authors:  Meaghan E Killeen; Laura Ferris; Erine A Kupetsky; Louis Falo; Alicia R Mathers
Journal:  J Immunol       Date:  2013-03-11       Impact factor: 5.422

Review 5.  Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors.

Authors:  Jenni E Anttila; Keith W Whitaker; Emily S Wires; Brandon K Harvey; Mikko Airavaara
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-07-04       Impact factor: 5.067

Review 6.  Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets.

Authors:  Kelly Juliana Filippin; Kamylla F S de Souza; Roberto Theodoro de Araujo Júnior; Heron Fernandes Vieira Torquato; Dhébora Albuquerque Dias; Eduardo Benedetti Parisotto; Alice Teixeira Ferreira; Edgar J Paredes-Gamero
Journal:  Purinergic Signal       Date:  2019-12-20       Impact factor: 3.765

7.  Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.

Authors:  Brent H Koehn; Asim Saha; Cameron McDonald-Hyman; Michael Loschi; Govindarajan Thangavelu; Lie Ma; Michael Zaiken; Josh Dysthe; Walker Krepps; Jamie Panthera; Keli Hippen; Stephen C Jameson; Jeffrey S Miller; Matthew A Cooper; Christopher J Farady; Takao Iwawaki; Jenny P-Y Ting; Jonathan S Serody; William J Murphy; Geoffrey R Hill; Peter J Murray; Vincenzo Bronte; David H Munn; Robert Zeiser; Bruce R Blazar
Journal:  Blood       Date:  2019-11-07       Impact factor: 25.476

8.  Is the inflammasome a potential therapeutic target in renal disease?

Authors:  Clare M Turner; Nishkantha Arulkumaran; Mervyn Singer; Robert J Unwin; Frederick W K Tam
Journal:  BMC Nephrol       Date:  2014-01-23       Impact factor: 2.388

Review 9.  Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases.

Authors:  Alexander J S Choi; Stefan W Ryter
Journal:  Mol Cells       Date:  2014-05-19       Impact factor: 5.034

10.  Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective.

Authors:  Jason C Lim; Wennan Lu; Jonathan M Beckel; Claire H Mitchell
Journal:  Front Cell Neurosci       Date:  2016-11-23       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.